# Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative Study

> **NCT06472258** · NA · COMPLETED · sponsor: **RESnTEC, Institute of Research** · enrollment: 104 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** IV Artesunate
- **DRUG:** IV Quinine Hydrochloride

## Key facts

- **NCT ID:** NCT06472258
- **Lead sponsor:** RESnTEC, Institute of Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2024-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06472258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06472258, "Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06472258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*